A new variant of the Omicron COVID strain - "Jenny": almost 10 cases registered in Ukraine in early 2024
Kyiv • UNN
In Ukraine, a new sub-variant of the Omicron strain, called "Jenny," has been identified and 9 cases have been reported in Sumy, Volyn, Cherkasy, Rivne, and Zaporizhzhia regions. The World Health Organization believes that the risk is low and that existing COVID-19 vaccines protect against it.
In January, most cases of the new sub-variant of the Omicron coronavirus strain were detected in Sumy region; cases were also reported in Volyn, Cherkasy, Rivne, and Zaporizhzhia regions.
This is reported by UNN with reference to the press service of the Ministry of Health of Ukraine.
Details
In January 2024, 9 cases of a new sub-variant of the coronavirus strain Omicron - JN.1, called "Jenny" - were reported in Ukraine. According to the Ministry of Health of Ukraine: 3 cases of the virus were detected in Sumy region, 2 cases in Volyn and Cherkasy regions, and one case each in Rivne and Zaporizhzhia regions. The patients are aged 27-73 years.
It is important to note that among those who fell ill in Ukraine, only one out of 9 people had 2 vaccinations against COVID-19. According to clinical symptoms, doctors recorded a moderate or mild course of the disease. However, as indicated, one person was hospitalized.
According to Chief State Sanitary Doctor Ihor Kuzin, the SARS-CoV-2 virus is constantly mutating, evading the immune response and striking weakened immune systems faster.
Even previously vaccinated people can get sick, but the acquired immunity after vaccination reduces the risk of complications during the disease. Therefore, people who have not completed the COVID-19 vaccination course and those at risk of severe disease should consult their family doctor and get vaccinated
At the same time, the WHO notes that in the case of JN.1, the risk to the public is low, and the vaccines used worldwide against COVID-19 protect against the new subvariant.
Recall
Swiss researchers have discovered a specific pattern in the blood of patients with long-term Covid: the discovery could revolutionize diagnosis and treatment: it involves proteins in patients' blood that indicate immune system dysfunction and chronic inflammation. Scientists hope to use the results of the study to better diagnose "long-lasting Covid" in the future and pave the way for more effective treatment of the disease.
